Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 7,016 across all filing types
Latest filing 2026-03-27 Foreign Filer Report
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
6-K - GSK plc (0001131399) (Filer)
Foreign Filer Report
2026-03-27 English
Bepirovirsen accepted for review by the EMA
Regulatory Filings Classification · 90% confidence The document is a Regulatory News Service (RNS) announcement issued via the London Stock Exchange. It provides corporate news about the acceptance of a marketing authorization application by the European Medicines Agency. It does not contain financial results, board changes, dividends, share transactions, or detailed report content—it is a general regulatory announcement. Therefore, it falls under the fallback ‘Regulatory Filings’ category (Code: RNS).
2026-03-27 English
Transaction in Own Shares
Transaction in Own Shares Classification · 98% confidence The document is an RNS announcement under the National Storage Mechanism describing GSK plc’s purchases of its own ordinary shares (buyback) with detailed transaction schedules and treasury share holding figures. This clearly falls under the “Transaction in Own Shares” category.
2026-03-27 English
6-K - GSK plc (0001131399) (Filer)
Foreign Filer Report
2026-03-26 English
Transaction in Own Shares
Transaction in Own Shares Classification · 94% confidence The document is clearly an RNS announcement titled “Transaction in own shares” by GSK plc. It details the number of shares repurchased, dates, prices, and volumes as part of a buyback programme. This matches the definition of “Transaction in Own Shares” (Code: POS), which covers corporate share repurchase activities.
2026-03-26 English
6-K - GSK plc (0001131399) (Filer)
Foreign Filer Report
2026-03-25 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.